How Long Should You Take Antidepressants? Treatment Timeline Explained
Author:
Blossom Editorial
Jun 12, 2026
A common question people have after starting an antidepressant is how long they will need to keep taking it.
The answer depends on your diagnosis, your history, and how you respond; most treatment guidelines recommend continuing for a period of time even after you feel better. Understanding the typical timeline can help you set realistic expectations and make informed decisions with your provider.
Key Takeaways
Treatment usually outlasts your symptoms: Most guidelines recommend staying on an antidepressant for several months after you feel well. This is done to lower the risk of relapse.
First episodes and recurrent depression differ: A first episode is often treated for several months post recovery, while people with repeated episodes may benefit from longer maintenance treatment.
Never stop abruptly: Tapering your antidepressant dose gradually while consulting your provider lowers the risk of both relapse and uncomfortable discontinuation symptoms.
The Three Phases of Antidepressant Treatment
There are three phases of depression treatment. Knowing where you are in this process can make the overall timeline easier to understand. These are:
Acute phase: This is the first stage, which is focused on relieving symptoms. This typically takes several weeks to a few months as you and your provider find an effective medication and dose.
Continuation phase: After depression symptoms lift, the treatment can continue to prevent the same episode from returning. This is the phase most guidelines have in mind when they recommend several more months of treatment
Maintenance phase: Longer-term treatment is used for people at higher risk of having another episode in the future.
Depression Treatment: How Long is Long Enough?
For a first episode of depression, professional guidelines generally recommend continuing an antidepressant for several months after you feel better, not stopping the moment your mood improves.
The American Psychiatric Association has long suggested roughly four to nine months of continuation treatment after symptoms remit, while other guidelines recommend at least six months.
A long-term study of fluoxetine (Prozac) published in the American Journal of Psychiatry found that people who continued treatment after recovering had lower relapse rates than those who switched to placebo, supporting continued treatment beyond the point of feeling well.
In practice, this means many people take an antidepressant for somewhere in the range of six months to a year for a first episode, though the exact length may vary.
What Impacts How Long You’ll Take an Antidepressant
No two treatment plans look exactly alike. Several factors shape how long your provider may recommend staying on medication:
Number of episodes you’ve had: A first episode is usually treated for months, while repeated episodes may call for longer treatment.
How quickly and fully you responded: A complete recovery, called remission, is the goal; partial improvement is linked to a higher chance of relapse in the short-term and recurrence in the longer term.
The condition being treated: Anxiety disorders and other mental health conditions often follow different recovery timelines than depression.
Your personal circumstances: Stress levels, other health conditions, and your own preferences all play a role in determining the length of your depression treatment.
When Longer-Term (Maintenance) Treatment Makes Sense
Some people benefit from staying on an antidepressant for longer, sometimes years. The decision usually depends on how likely a future episode is. Factors that may point toward longer maintenance treatment include:
A history of multiple episodes: People who have had several episodes of depression are generally at higher risk of recurrence.
Severe or hard-to-treat episodes: More severe depression, psychotic episodes, or episodes that were difficult to treat may warrant longer protection.
Ongoing risk factors: Persistent stressors, other mental health conditions, or a strong family history can also influence the plan.
For these situations, the goal expands from resolving the current episode to preventing a new one. The National Institute of Mental Health emphasizes that the treatment length for depression should be individualized with your provider.
How Likely is Depression to Return?
Depression is often a recurring condition, and the chances of future episodes tend to increase over time, making continuing treatment imperative. Research has shown a well-known pattern: after a first episode, roughly half of people (40-60%) will have another; after a second episode, the risk rises to about 70%; and after a third, it climbs to around 90%.
Staying on treatment for the recommended period may help with changing those odds. Moreover, stopping an antidepressant once symptoms lift is associated with recurrence in roughly 40-50% of people, while continuing treatment for 6 to 12 months after recovery lowers that risk to about 13-20%.
How Long for Anxiety Disorders?
Antidepressants are also a first-line treatment for anxiety disorders, and the timelines there can run a little longer than for a single episode of depression. For generalized anxiety disorder, evidence-based guidance recommends continuing treatment for 6-12 months after a good response, since anxiety symptoms in GAD often follow a waxing and waning course.
As with depression, the exact length is individualized. The general principle is the same across both conditions: give the medication enough time to help consolidate your progress before thinking about stopping it.
Why Stopping Too Soon Raises Relapse Risk
Stopping an antidepressant before the recommended time may lead to relapse, which is an early return or worsening of symptoms. Antidepressants can ease symptoms before the underlying episode has fully resolved, leaving a window where stopping early makes a relapse more likely.
Moreover, people who continue to experience some residual symptoms of depression are more likely to have recurrent episodes later on. To avoid this, your provider would typically advise you to continue taking the medication until full remission.
If you are weighing how long to stay on your medication, you can discuss your treatment plan with a psychiatric provider.
Antidepressants and Dependence: A Common Worry
Many people worry that taking an antidepressant for months or years could make them "addicted." It is essential to differentiate addiction from what happens during antidepressant discontinuation.
Antidepressants such as selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) are not considered addictive like other substances people misuse; they do not cause cravings or a high.
What can happen is that the body adjusts to the medication, so stopping suddenly may cause temporary discontinuation symptoms. That is a reason to taper gradually and does not represent addiction.
Understanding this distinction can make it easier to follow the recommended treatment length without unnecessary fear.
How Antidepressants Are Safely Stopped
When it is time to stop, the medication is usually reduced gradually rather than stopped all at once.
Tapering can help lower the chance of discontinuation symptoms, which can include flu-like feelings, dizziness, mood changes, or sensations sometimes described as "brain zaps”. Research suggests that slow tapering may help lower the risk of relapse compared to stopping abruptly. The pace of the taper depends on the specific medication and how long you have been taking it.
It is important to note that antidepressant discontinuation symptoms and relapse are two different things; while discontinuation symptoms occur as a result of stopping or reducing an antidepressant, relapse occurs when symptoms of depression return after improvement but before recovery from the current episode is fully established.
Discontinuation symptoms often appear within 2-4 days of stopping or reducing the medication and may include symptoms such as dizziness, nausea, and brain zaps. Relapse, however, takes weeks or a few months to appear and has symptoms similar to the original episode.
How to Get Help
Ongoing support is vital while you are on antidepressant treatment. Blossom Health connects you with board-certified psychiatrists who can evaluate your symptoms, prescribe and adjust your antidepressant medications when needed, and monitor your progress over time. With convenient online appointments and insurance-covered care, you can get personalized support every step of your treatment journey. Get started today!
Medical Disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice. Always talk with your physician or another qualified healthcare provider about any questions you have regarding a medical condition or your medications. If you are experiencing a mental health crisis, contact the 988 Suicide and Crisis Lifeline by calling or texting 988.
Sources
Melfi CA et al. 1998. The Effects of Adherence to Antidepressant Treatment Guidelines on Relapse and Recurrence of Depression. Arch Gen Psychiatry. jamanetwork.com
Jung, W. Y., Jang, S. H., Kim, S. G., Jae, Y. M., Kong, B. G., Kim, H. C., Choe, B. M., Kim, J. G., & Kim, C. R. (2016). Times to Discontinue Antidepressants Over 6 Months in Patients with Major Depressive Disorder. Psychiatry investigation, 13(4), 440–446. https://doi.org/10.4306/pi.2016.13.4.440
Reimherr FW ET AL. 1998. Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment. Am J Psychiatry. https://pubmed.ncbi.nlm.nih.gov/9734550/
Hu Y et al. 2024. Association between duration of antidepressant treatment for major depressive disorder and relapse rate after discontinuation: A meta-analysis. Psychiatry Res. https://pubmed.ncbi.nlm.nih.gov/38733930/
National Institute of Mental Health (NIMH). Depression. nimh.nih.gov
National Institute of Mental Health (NIMH). Mental Health Medications. nimh.nih.gov
Mayo Clinic. Antidepressants: Selecting One That’s Right for You. mayoclinic.org
Nuggerud-Galeas S et al., 2020. Analysis of depressive episodes, their recurrence and pharmacologic treatment in primary care patients: A retrospective descriptive study. PLoS One. ncbi.nlm.nih.gov
David S. Baldwin, Sarah Waldman, Christer Allgulander. 2011. Evidence-based pharmacological treatment of generalized anxiety disorder, International Journal of Neuropsychopharmacology. academic.oup.com
Shelton R. C. (2001). Steps Following Attainment of Remission: Discontinuation of Antidepressant Therapy. Primary care companion to the Journal of clinical psychiatry, 3(4), 168–174. https://doi.org/10.4088/pcc.v03n0404
Gøtzsche, P. C., & Demasi, M. (2024). Interventions to help patients withdraw from depression drugs: A systematic review. The International journal of risk & safety in medicine, 35(2), 103–116. https://doi.org/10.3233/JRS-230011
